News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research> Jefferies Raises TP for CSPC Pharmaceutical Group (01093.HK) to HKD7.2, Maintains 'Underperform' Rating
Jefferies published a research report stating that CSPC Pharmaceutical Group (01093.HK) still faced pressure in its performance last year, with annual revenue declining by 10% year...
Reset
Send
The window will close in 5 seconds
<Research> Jefferies Raises TP for CSPC Pharmaceutical Group (01093.HK) to HKD7.2, Maintains 'Underperform' Rating
Close
Recommend
6
Positive
13
Negative
6
 
 

Jefferies published a research report stating that CSPC Pharmaceutical Group (01093.HK)  +0.090 (+0.936%)    Short selling $314.42M; Ratio 92.374%   still faced pressure in its performance last year, with annual revenue declining by 10% year-on-year to RMB260 billion, which was below expectations. Although management expects the finished drug business to return to positive growth this year, the market is concerned about potential Volume-Based Procurement (VBP) risks, including the possible inclusion of Irinotecan Hydrochloride Liposome Injection in the national VBP.

Jefferies believes that the adverse factors of VBP are expected to persist this year. While Business Development (BD) is crucial, the market continues to bet on stock prices based on prepayment expectations, and with expectations being raised, the risk of disappointment is increasing.

The firm maintains an 'Underperform' rating for CSPC but raises the target price from HKD5.9 to HKD7.2. (hc/w)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.